Galt Pharmaceuticals

Franchise Information

Analyzed filing: CA · File #4755

Filed: Jul 21, 2026

FDD Issued: Apr 6, 2026

Extracted: Aug 23, 2026

Analyzed

Franchisor Details

Name: Galt Phranchise Systems, LLC

Parent: Galt Companies, LLC

Address: 3350 Riverwood Parkway, Suite 1900, Atlanta, Georgia 30339

Phone: 855-965-2783

Website: www.galtps.com

Franchising Since: 2018

Industry & Qualifications

Industry

Health & Medical

Franchise Fee

$100,000 - $300,000

Royalty

Not disclosed

Total Investment

$122K - $349K

Initial Term

5 years

Renewable

Outlet Information

Total Outlets (2025)

Franchised

Opened (Last Year)

+14

Closed (Last Year)

-20

Churn Breakdown (Last Year)

Terminations

Non-Renewals

Ceased Ops

Transfers

Reacquired

Item 19 (Financial Performance)

Disclosed

24 Operational Franchise Outlets (53 territories) operating the full 2025 calend...

Financial Performance (Item 19)

Avg Unit Volume (through Dec 2025)

$353,017

Highest

$2,055,300

Sample Size

24 units

Legal History

Litigation: None

Bankruptcy: None

Number	File name	Source State	Filing Date	Actions
4755	CA_APP00004755.pdf Canonical 2026 analysis · newest filing	CA	Jul 21, 2026	Restricted
2204	CA_APP00002204.pdf Alternate source copy	CA	Jul 17, 2026	Restricted
254567	487839_Franchise__Galt_Pharmaceuticals_EFDID__4_New York_254567.pdf Alternate source copy	NY	Apr 23, 2025 FDD issue date	Restricted
235013	487839_Franchise__Galt_Pharmaceuticals_EFDID__4_Illinois_235013.pdf Alternate source copy	IL	Apr 23, 2025 FDD issue date	Restricted
263298	487839_Franchise__Galt_Pharmaceuticals_EFDID__4_Virginia_263298.pdf Canonical 2025 analysis	VA	Apr 23, 2025 FDD issue date	Restricted
166824	487839_Franchise__Galt_Pharmaceuticals_EFDID__4_New York_166824.pdf Canonical 2024 analysis	NY	Apr 29, 2024 FDD issue date	Restricted
104251	487839_Franchise__Galt_Pharmaceuticals_EFDID__4_New York_104251.pdf Canonical 2023 analysis	NY	May 9, 2023 FDD issue date	Restricted

Showing 1–7 of 7 files.